Ren, Hongyan
Fabbri, Chiara
Uher, Rudolf
Rietschel, Marcella http://orcid.org/0000-0002-5236-6149
Mors, Ole
Henigsberg, Neven http://orcid.org/0000-0002-5303-1834
Hauser, Joanna
Zobel, Astrid
Maier, Wolfgang
Dernovsek, Mojca Z.
Souery, Daniel
Cattaneo, Annamaria
Breen, Gerome
Craig, Ian W.
Farmer, Anne E.
McGuffin, Peter
Lewis, Cathryn M. http://orcid.org/0000-0002-8249-8476
Aitchison, Katherine J. http://orcid.org/0000-0002-1107-3024
Article History
Received: 29 March 2017
Revised: 17 February 2018
Accepted: 26 March 2018
First Online: 13 August 2018
Conflict of interest
: K.J.A. was previously a member of various advisory boards, received consultancy fees and honoraria, and has received research grants from various companies including Johnson and Johnson Pharmaceuticals Research and Development, Bristol-Myers Squibb Pharmaceuticals Limited, Janssen Inc., Canada, and has provided consultancy services for Otsuka Canada Pharmaceutical Inc., and Lundbeck Canada. W.M., A.E.F., and P.M. have received consultancy fees and honoraria for participating in expert panels from pharmaceutical companies including Lundbeck and GlaxoSmithKline. N.H. has participated in clinical trials sponsored by pharmaceutical companies including GlaxoSmithKline and Lundbeck and has received honoraria for participating in expert panels from pharmaceutical companies including Lundbeck. D.S. is a member of the national advisory boards for Astra-Zeneca, Bristol-Myers Squibb, Eli Lilly, and Lundbeck.